Trials / Completed
CompletedNCT03097510
Meditation and Emotional Intelligence
Meditation and Emotional Intelligence: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Maharishi International University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This randomized controlled trial evaluated the impact of the Transcendental Meditation program on emotional intelligence and perceived stress in supervisors and administrative staff in a public school system
Detailed description
The objective of this study was to determine whether a mind-body technique, known as the practice of Transcendental Meditation® (TM), could significantly increase emotional intelligence and decrease perceived stress in supervisors and administrative staff in a public school system. For this purpose, 96 participants from the administrative offices of the San Francisco Unified School District were randomly assigned to either immediate start of the TM program or to a delayed start wait-list control group. Subjects learning TM were instructed to meditate for 20 minutes twice a day for the four month duration of the project. All subjects were administered the BarOn Emotional Quotient Inventory (EQ-i) and Perceived Stress Scale (PSS) at baseline and posttest. If successful, these findings would suggest that TM could be used as a professional development program in organizations to increase emotional intelligence and decrease perceived stress, in turn enhancing leadership capacity and organizational effectiveness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Transcendental meditation | The TM technique was taught as a standard 7 step course over 4 consecutive days. Thereafter, subjects attended bimonthly group meetings for more advanced knowledge over the four month intervention period. |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2011-01-01
- Completion
- 2011-03-01
- First posted
- 2017-03-31
- Last updated
- 2017-03-31
Source: ClinicalTrials.gov record NCT03097510. Inclusion in this directory is not an endorsement.